Google News title UK plans to begin treatment for fibroadensoma using cannabis article The UK will start using cannabis to treat fibroadenic malignancies and to reduce the frequency of infections, according to a government report.
The move follows a survey of the medical community by the Department of Health (DH) which found that about 50 per cent of patients with fibroadendomas and around half of those with other forms of cancer were suffering from pain and nausea due to the condition.
However, the report said the current drugs, which are mainly prescribed to relieve symptoms and treat infections, were “not a proven and safe treatment for the majority of patients”.
“Currently, the only approved drug is ibuprofen,” said the DH.
The report also said there were “no clear guidelines” on how to prescribe cannabis to patients suffering from fibroadentomas, and the drugs had not been adequately evaluated for their effectiveness. “
They can cause serious side effects, such as heart palpitations, dizziness, weakness, and memory loss.”
The report also said there were “no clear guidelines” on how to prescribe cannabis to patients suffering from fibroadentomas, and the drugs had not been adequately evaluated for their effectiveness.
“[Doctors] do not know how long they should be on it, whether it is safe or not,” the DH added.
Currently, patients can only take a small dose of cannabis to help ease the pain and symptoms, and only at prescribed times, said the report.
“We recommend that patients are encouraged to use cannabis regularly.”
“Our government will work with the medical and scientific community to develop a strategy for the development and use of cannabis as a treatment for Fibroadenomatous Malignancies (FGM), and other cancer-related conditions,” it added.